Cymbiotika, a Bioactive Supplement Brand, Raises $25M in Celebrity-Filled Found
The San Diego-based brand reeled in a star-studded seed funding round as it launches its first large-scale campaign across the U.S.
Cymbiotika, a bioactive supplement brand known for delivering products in liquid and gel forms, has secured a $25 million seed round after reaching $150 million in annual revenue.
The raise, which includes a roster of investors spanning music, sports, and culture, marks a defining moment for the San Diego-based company as it enters all Target stores nationwide and launches its first large-scale brand campaign.
The funding round includes The Weeknd, Post Malone, Peggy Gou, the Jonas Brothers, Marshmello, Daymond John, and pro skateboarder Nyjah Huston, with a total of more than 50 notable backers. Investors also include David and Isabela Grutman, Guy Oseary, Ryan Tedder, Steve Aoki, and tennis champion Stan Wawrinka, reflecting growing interest in health and recovery investments.
Cymbiotika has had five consecutive years of triple-digit growth and a dedicated community drawn to its clean, bioavailable formulations, attracting investment attention.
“This is a collective of people who believe in what Cymbiotika represents — wellness that’s aspirational, accessible, and artful,” brand said in announcing the round. “It’s not just a product; it’s a lifestyle shift.”
The funding will accelerate Cymbiotika’s expansion into retail, innovation in functional nutrition and its creative ambitions.
The company recently unveiled its first-ever nationwide brand campaign, anchored by a 50-foot art installation in Minneapolis, Target’s hometown, that embodies its “wellness as living art” ethos. More than 1,450 out-of-home placements will roll out nationwide across billboards, gyms, and salons, followed by a multi-city Wellness Tour through 2026, including stops in Miami during Art Basel and Las Vegas during March Madness.
The campaign arrives just weeks after Cymbiotika’s official Target launch in October, signaling a new phase of accessibility for a brand that has long occupied the premium direct-to-consumer space. In December, it will debut 900-store endcaps and new two-pack SKUs in Target’s $5 section, designed to introduce its functional formulas to first-time buyers.